NO2515886T3 - - Google Patents
Info
- Publication number
- NO2515886T3 NO2515886T3 NO10790565A NO10790565A NO2515886T3 NO 2515886 T3 NO2515886 T3 NO 2515886T3 NO 10790565 A NO10790565 A NO 10790565A NO 10790565 A NO10790565 A NO 10790565A NO 2515886 T3 NO2515886 T3 NO 2515886T3
- Authority
- NO
- Norway
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F13/00051—Accessories for dressings
- A61F13/00063—Accessories for dressings comprising medicaments or additives, e.g. odor control, PH control, debriding, antimicrobic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F13/00987—Apparatus or processes for manufacturing non-adhesive dressings or bandages
- A61F13/00991—Apparatus or processes for manufacturing non-adhesive dressings or bandages for treating webs, e.g. for moisturising, coating, impregnating or applying powder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T156/00—Adhesive bonding and miscellaneous chemical manufacture
- Y10T156/10—Methods of surface bonding and/or assembly therefor
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Biomedical Technology (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Emergency Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Manufacturing & Machinery (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Psychology (AREA)
- Inorganic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Materials For Medical Uses (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP09180413 | 2009-12-22 | ||
EP10154648 | 2010-02-25 | ||
PCT/EP2010/069654 WO2011076621A2 (de) | 2009-12-22 | 2010-12-14 | Transdermales therapeutisches system zur verabreichung von rivastigmin oder dessen derivaten |
EP10790565.5A EP2515886B1 (de) | 2009-12-22 | 2010-12-14 | Transdermales therapeutisches system zur verabreichung von rivastigmin oder dessen derivaten |
Publications (1)
Publication Number | Publication Date |
---|---|
NO2515886T3 true NO2515886T3 (es) | 2018-09-08 |
Family
ID=43383419
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO10790565A NO2515886T3 (es) | 2009-12-22 | 2010-12-14 |
Country Status (16)
Country | Link |
---|---|
US (1) | US8962014B2 (es) |
EP (1) | EP2515886B1 (es) |
JP (1) | JP6083734B2 (es) |
KR (1) | KR101674240B1 (es) |
CN (1) | CN102711744B (es) |
AU (1) | AU2010335309B2 (es) |
BR (1) | BR112012017168B1 (es) |
CA (1) | CA2785117C (es) |
CY (1) | CY1120283T1 (es) |
DK (1) | DK2515886T3 (es) |
ES (1) | ES2670227T3 (es) |
MX (1) | MX350357B (es) |
NO (1) | NO2515886T3 (es) |
PL (1) | PL2515886T3 (es) |
PT (1) | PT2515886T (es) |
WO (1) | WO2011076621A2 (es) |
Families Citing this family (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102933207B (zh) | 2009-10-30 | 2018-02-02 | Ix生物医药有限公司 | 快速溶解固体剂型 |
DE102010026903A1 (de) | 2010-07-12 | 2012-01-12 | Amw Gmbh | Transdermales therapeutisches System mit Avocadoöl oder Palmöl als Hilfsstoff |
HUE027916T2 (en) * | 2010-12-14 | 2016-11-28 | Acino Ag | Transdermal therapeutic system for administration of an active ingredient |
US9585862B2 (en) * | 2011-05-20 | 2017-03-07 | Sk Chemicals Co., Ltd. | Patch containing rivastigmine |
CA2841785A1 (en) | 2011-07-06 | 2013-01-10 | The Parkinson's Institute | Compositions and methods for treatment of symptoms in parkinson's disease patients |
JP6102739B2 (ja) * | 2011-08-31 | 2017-03-29 | 東洋インキScホールディングス株式会社 | 貼付剤 |
EP2594261A1 (en) | 2011-11-18 | 2013-05-22 | Labtec GmbH | Composition for transdermal administration of rivastigmine |
DE102012000369A1 (de) | 2012-01-11 | 2013-07-11 | Alfred E. Tiefenbacher (Gmbh & Co. Kg) | Transdermales therapeutisches System mit Cholinesterase-Hemmer |
SG11201404815YA (en) | 2012-02-28 | 2014-10-30 | Nichiban Kk | Transdermal patch |
US20140083878A1 (en) * | 2012-09-21 | 2014-03-27 | Mylan Inc. | Transdermal drug delivery device |
CN103933018A (zh) * | 2013-01-18 | 2014-07-23 | 江苏康倍得药业有限公司 | 一种透皮给药系统 |
US20180271800A1 (en) | 2017-03-24 | 2018-09-27 | E Ink California, Llc | Microcell systems for delivering active molecules |
JPWO2015174502A1 (ja) | 2014-05-15 | 2017-05-25 | ニチバン株式会社 | リバスチグミンを含有する貼付剤のための包装体 |
CA2962059C (en) * | 2014-09-23 | 2020-03-24 | Equistar Chemicals, Lp | Polyolefin-based compositions, adhesives, and related multi-layered structures prepared therefrom |
CA2974324A1 (en) | 2015-01-28 | 2016-08-04 | Zita S. Netzel | Drug delivery methods and systems |
JP2018511127A (ja) | 2015-03-12 | 2018-04-19 | クロノ セラピューティクス インコーポレイテッドChrono Therapeutics Inc. | 渇望入力及び支援システム |
DE102015119789A1 (de) * | 2015-11-16 | 2017-05-18 | Denso-Holding Gmbh & Co. | Korrosionsschutzzusammensetzung umfassend Polyisobutylene |
WO2018129304A1 (en) | 2017-01-06 | 2018-07-12 | Chrono Therapeutics Inc. | Transdermal drug delivery devices and methods |
CN110446491A (zh) | 2017-03-24 | 2019-11-12 | 伊英克加利福尼亚有限责任公司 | 调节活性物质给予速率的包含带电粒子或磁性粒子的微单元递送系统 |
CN111295182A (zh) | 2017-11-14 | 2020-06-16 | 伊英克加利福尼亚有限责任公司 | 包括多孔导电电极层的电泳活性物质递送系统 |
BR112020021173A2 (pt) * | 2018-04-17 | 2021-01-19 | Lts Lohmann Therapie-Systeme Ag | Sistema terapêutico transdérmico para a administração transdérmica de solifenacina |
US11596779B2 (en) | 2018-05-29 | 2023-03-07 | Morningside Venture Investments Limited | Drug delivery methods and systems |
KR20220074962A (ko) | 2019-11-27 | 2022-06-03 | 이 잉크 캘리포니아 엘엘씨 | 전기 침식 밀봉층을 갖는 마이크로셀들을 포함하는 유익제 전달 시스템 |
EP4236927A1 (en) | 2020-10-29 | 2023-09-06 | E Ink California, LLC | Microcell systems for delivering hydrophilic active molecules |
WO2022093541A1 (en) | 2020-10-29 | 2022-05-05 | E Ink California, Llc | Microcell systems for delivering benefit agents |
Family Cites Families (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NL195004C (nl) | 1987-03-04 | 2003-11-04 | Novartis Ag | Fenylcarbamaat bevattend farmaceutisch preparaat. |
JPS63307818A (ja) * | 1987-06-08 | 1988-12-15 | Sekisui Chem Co Ltd | 経皮吸収貼付剤 |
JPH07116025B2 (ja) * | 1988-03-11 | 1995-12-13 | 積水化学工業株式会社 | 貼付剤 |
JP2693212B2 (ja) * | 1989-03-28 | 1997-12-24 | 日東電工株式会社 | 疾患治療用テープ製剤 |
JPH08193030A (ja) * | 1995-01-12 | 1996-07-30 | Nitto Denko Corp | エメダスチン貼付製剤 |
JPH10152434A (ja) | 1996-09-26 | 1998-06-09 | Nitto Denko Corp | 経皮吸収型製剤 |
GB9800526D0 (en) | 1998-01-12 | 1998-03-11 | Ciba Geigy Ag | Organic compounds |
DE19814087A1 (de) * | 1998-03-30 | 1999-10-14 | Lohmann Therapie Syst Lts | Feuchtigkeitsaktivierbares therapeutisches System |
DE19918106A1 (de) * | 1999-04-22 | 2000-10-26 | Lohmann Therapie Syst Lts | Transdermales therapeutisches System mit neutralisierten Acrylathaftklebern |
DE10033853A1 (de) * | 2000-07-12 | 2002-01-31 | Hexal Ag | Transdermales therapeutisches System mit hochdispersem Siliziumdioxid |
DE10141652B4 (de) * | 2001-08-24 | 2011-04-07 | Lts Lohmann Therapie-Systeme Ag | Transdermales therapeutisches System auf der Basis von Polyacrylat-Haftklebern ohne funktionelle Gruppen und seine Verwendung |
WO2003032960A1 (fr) * | 2001-10-17 | 2003-04-24 | Hisamitsu Pharmaceutical Co., Inc. | Preparations pour absorption percutanee |
JP4478757B2 (ja) * | 2002-04-19 | 2010-06-09 | 日東電工株式会社 | ビソプロロール含有貼付剤 |
RU2401125C2 (ru) * | 2004-12-27 | 2010-10-10 | Эйсай Ар Энд Ди Менеджмент Ко., Лтд. | Способ стабилизации лекарственного средства против деменции |
TWI389709B (zh) * | 2005-12-01 | 2013-03-21 | Novartis Ag | 經皮治療系統 |
CN1994290B (zh) * | 2006-01-04 | 2011-03-16 | 上海医药工业研究院 | 卡巴拉汀透皮贴剂及其制备方法 |
EP2016939B1 (en) * | 2006-05-08 | 2014-03-19 | Teikoku Seiyaku Co., Ltd. | Transdermally absorbable preparation comprising anti-dementia agent |
US9248104B2 (en) * | 2006-08-17 | 2016-02-02 | Core Tech Solutions, Inc. | Transdermal methods and systems for treating Alzheimer's disease |
JP2009022730A (ja) * | 2007-06-18 | 2009-02-05 | Kyoritsu Yakuhin Kogyo Kk | 貼付剤 |
-
2010
- 2010-12-14 KR KR1020127017374A patent/KR101674240B1/ko active IP Right Grant
- 2010-12-14 ES ES10790565.5T patent/ES2670227T3/es active Active
- 2010-12-14 AU AU2010335309A patent/AU2010335309B2/en active Active
- 2010-12-14 NO NO10790565A patent/NO2515886T3/no unknown
- 2010-12-14 PT PT107905655T patent/PT2515886T/pt unknown
- 2010-12-14 BR BR112012017168-2A patent/BR112012017168B1/pt active IP Right Grant
- 2010-12-14 US US13/518,006 patent/US8962014B2/en active Active
- 2010-12-14 EP EP10790565.5A patent/EP2515886B1/de active Active
- 2010-12-14 WO PCT/EP2010/069654 patent/WO2011076621A2/de active Application Filing
- 2010-12-14 MX MX2012007214A patent/MX350357B/es active IP Right Grant
- 2010-12-14 DK DK10790565.5T patent/DK2515886T3/en active
- 2010-12-14 PL PL10790565T patent/PL2515886T3/pl unknown
- 2010-12-14 CA CA2785117A patent/CA2785117C/en active Active
- 2010-12-14 CN CN201080059296.4A patent/CN102711744B/zh active Active
- 2010-12-14 JP JP2012545226A patent/JP6083734B2/ja active Active
-
2018
- 2018-05-25 CY CY20181100570T patent/CY1120283T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
EP2515886B1 (de) | 2018-04-11 |
US8962014B2 (en) | 2015-02-24 |
AU2010335309A1 (en) | 2012-07-19 |
JP6083734B2 (ja) | 2017-02-22 |
BR112012017168B1 (pt) | 2022-03-15 |
ES2670227T3 (es) | 2018-05-29 |
KR101674240B1 (ko) | 2016-11-08 |
PL2515886T3 (pl) | 2018-08-31 |
WO2011076621A2 (de) | 2011-06-30 |
CA2785117C (en) | 2016-12-06 |
CA2785117A1 (en) | 2011-06-30 |
DK2515886T3 (en) | 2018-06-14 |
CY1120283T1 (el) | 2019-07-10 |
MX350357B (es) | 2017-09-05 |
EP2515886A2 (de) | 2012-10-31 |
CN102711744B (zh) | 2014-06-25 |
MX2012007214A (es) | 2012-09-12 |
AU2010335309B2 (en) | 2015-08-20 |
JP2013515025A (ja) | 2013-05-02 |
PT2515886T (pt) | 2018-05-23 |
WO2011076621A3 (de) | 2012-02-09 |
KR20120128606A (ko) | 2012-11-27 |
BR112012017168A2 (pt) | 2018-05-02 |
CN102711744A (zh) | 2012-10-03 |
US20130261571A1 (en) | 2013-10-03 |